We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Kyowa Kirin Limited has notified MHRA that the priming instructions in the current PIL for Tostran 2% gel require updating.
MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
First published during the 2019 to 2022 Johnson Conservative government
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Employment Tribunal decision.
Exception to the general rule for which healthcare professionals can sell, supply, and/ or administer medicines to patients also known as exemptions.
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Guidance for industry and organisations to follow from 1 January 2021.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).